New questionnaire could let breast cancer patients skip some hospital trips

NCT ID NCT07190651

Not yet recruiting Symptom relief Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a simple home questionnaire for women with HR+HER2- advanced breast cancer who are taking CDK4/6 inhibitors and hormone therapy. The goal is to see if the questionnaire can accurately identify which patients truly need to come to the hospital for a check-up, potentially allowing others to stay home. Fifty participants will fill out the questionnaire at each 28-day treatment cycle, and researchers will compare the results with in-person exams.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: home questionnaire
What this could lead to: If successful, this could allow patients to safely skip some hospital visits, improving quality of life and reducing healthcare burden.
What could go wrong: This is a small, early-stage study (50 participants) testing a questionnaire, not a treatment. It may not accurately identify who needs hospital care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CDK4/6 INHIBITOR

More trials for these conditions

Other studies related to the condition(s) this trial covers.